WFDC2 and ovarian carcinoma: Since ORF1p expression is observed across a wide range of ovarian cancer samples and is independent of HE4 and CA-125, we postulate that ORF1p may serve as a useful analyte in a multi-modal, multi-biomarker screening tool for ovarian cancer.